Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

anticachexia agent OC514

A combination agent composed of two active ingredients, with potential anti-cachexia and anti-sarcopenia activities. Upon administration of OC514, the two active ingredients exert their mechanism of action (MoA) through an as of yet undisclosed manner to potentially prevent or decrease loss of skeletal muscle mass and strength.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Code name:	OC 514 OC-514 OC514

anticachexia agent OC514

Search NCI's Drug Dictionary